Tech News
← Home  ·  All topics

Cleveland

5 GoKawiil briefs on this topic

Hacker News user seeks Cleveland ham radio club contact to rescue gear from disposal

A Hacker News poster says they submitted a web form to the Cuyahoga Amateur Radio Club describing a large collection of radio equipment, including unused items, that must be cleared from a home or else discarded. They worry the submission has gone unanswered and are asking the community for a direct contact at the club to ensure the message is seen before the gear is thrown out.

Clase and Ortiz pitch-tipping fraud trial opens in Brooklyn federal court

Former Cleveland Guardians pitchers Emmanuel Clase and Luis Ortiz began trial Monday on charges they took bribes to help gamblers win over $460,000 betting on individual pitches. Prosecutors allege Clase started feeding pitch information to bettors in 2023 and brought Ortiz into the scheme in 2025; both have pleaded not guilty to wire fraud, money laundering and bribery-related conspiracy charges and remain on unpaid nondisciplinary leave.

Binance, Polymarket Halt Trading Following Separate Hack Incidents

Crypto exchange Binance and prediction market Polymarket both suspended trading after suffering hacks, according to a Wall Street Journal risk report roundup. The same report notes the Trump administration offered tariff relief during talks to secure a U.S. Audi factory, and that Cleveland-Cliffs will retain Stelco amid a jobs dispute with Canada's government.

Cleveland.com Publishes AI-Generated Article Under Reporter's Name Without Consent

Cleveland.com reporter Kaitlin Durbin says the outlet's AI-driven 'Express Desk' published a story about a Cuyahoga County official under her byline while she was on her honeymoon, though she never wrote or reviewed it. The story, unrelated to her prior work, was later corrected to remove her name after she publicly objected on X.

CRISPR gene-editing therapy sustains 50% cholesterol drop for a full year, Cleveland Clinic finds

An updated study published in the New England Journal of Medicine shows that a one-time CRISPR-Cas9 gene-editing infusion kept LDL cholesterol and triglycerides roughly 50% lower a full year after treatment in patients who received the highest dose. The follow-up builds on a small November 2025 pilot trial of 15 patients with medication-resistant high cholesterol, testing five dosage levels for safety, with researchers now confirming the effect appears durable rather than temporary.